Greenspring Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Greenspring Advisors's AMGN Position: Q1 2026 in Review
Greenspring Advisors increased its Amgen (AMGN) stake by 9.8% in Q1 2026, buying an estimated $215K and bringing the position to 6,722 shares worth $2.37M. The position accounts for 0.14% of the portfolio, ranked #78.
Greenspring Advisors first reported a position in AMGN in Q4 2021 and has held it in 17 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Greenspring Advisors held 6,722 shares of Amgen worth $2.37M as of Q1 2026.
- Greenspring Advisors bought 602 Amgen shares in Q1 2026, an estimated $215K.
- Amgen made up 0.14% of Greenspring Advisors's portfolio in Q1 2026, its #78 holding.
- Greenspring Advisors first reported a position in Amgen in Q4 2021 and has held it in 17 quarters since.
- 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Greenspring Advisors's 13F filing for Q1 2026, filed 5 May 2026.